Cargando…
Prolyl oligopeptidase inhibition reduces PolyQ aggregation and improves cell viability in cellular model of Huntington’s disease
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850970/ https://www.ncbi.nlm.nih.gov/pubmed/31565846 http://dx.doi.org/10.1111/jcmm.14675 |
| _version_ | 1783469543752990720 |
|---|---|
| author | Norrbacka, Susanna Lindholm, Dan Myöhänen, Timo T. |
| author_facet | Norrbacka, Susanna Lindholm, Dan Myöhänen, Timo T. |
| author_sort | Norrbacka, Susanna |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6850970 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68509702019-12-01 Prolyl oligopeptidase inhibition reduces PolyQ aggregation and improves cell viability in cellular model of Huntington’s disease Norrbacka, Susanna Lindholm, Dan Myöhänen, Timo T. J Cell Mol Med Short Communications John Wiley and Sons Inc. 2019-09-29 2019-12 /pmc/articles/PMC6850970/ /pubmed/31565846 http://dx.doi.org/10.1111/jcmm.14675 Text en © 2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Short Communications Norrbacka, Susanna Lindholm, Dan Myöhänen, Timo T. Prolyl oligopeptidase inhibition reduces PolyQ aggregation and improves cell viability in cellular model of Huntington’s disease |
| title | Prolyl oligopeptidase inhibition reduces PolyQ aggregation and improves cell viability in cellular model of Huntington’s disease |
| title_full | Prolyl oligopeptidase inhibition reduces PolyQ aggregation and improves cell viability in cellular model of Huntington’s disease |
| title_fullStr | Prolyl oligopeptidase inhibition reduces PolyQ aggregation and improves cell viability in cellular model of Huntington’s disease |
| title_full_unstemmed | Prolyl oligopeptidase inhibition reduces PolyQ aggregation and improves cell viability in cellular model of Huntington’s disease |
| title_short | Prolyl oligopeptidase inhibition reduces PolyQ aggregation and improves cell viability in cellular model of Huntington’s disease |
| title_sort | prolyl oligopeptidase inhibition reduces polyq aggregation and improves cell viability in cellular model of huntington’s disease |
| topic | Short Communications |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850970/ https://www.ncbi.nlm.nih.gov/pubmed/31565846 http://dx.doi.org/10.1111/jcmm.14675 |
| work_keys_str_mv | AT norrbackasusanna prolyloligopeptidaseinhibitionreducespolyqaggregationandimprovescellviabilityincellularmodelofhuntingtonsdisease AT lindholmdan prolyloligopeptidaseinhibitionreducespolyqaggregationandimprovescellviabilityincellularmodelofhuntingtonsdisease AT myohanentimot prolyloligopeptidaseinhibitionreducespolyqaggregationandimprovescellviabilityincellularmodelofhuntingtonsdisease |